TB

This monograph is a menu intended as a practical resource for public health officials and their legal counsel in their efforts to eliminate TB. It contains TB-related legal issues, and suggests possible approaches for addressing those issues, and provisions to be considered within the policy and legal frameworks of the jurisdiction contemplating adoption of the suggested provision. Each section of the menu has a brief note describing the purpose of the provisions included in the section.

The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.

The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.

This webinar introduces the topic of Electronic Medical Records (EMRs) and its application in TB programs. The content will address basic features of an EMR, benefits and challenges of EMR incorporation, as well as tools and strategies to tailor EMRs specifically for TB programs. The format includes two case studies, followed by a moderated discussion.

These new guidelines supersede previous WHO policy documents on the management of LTBI in people living with HIV, household contacts of people with active TB, other groups at risk of developing TB, and for LTBI testing. The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants.

Guided video for patients who have to collect their sputum during a medical visit.

This guide is for people with tuberculosis (TB), people at risk for TB, and their caretakers. The guide contains information on what services you have the right to receive, as well as your rights related to TB prevention, testing, treatment, and care.

This information sheet discusses preventing occupational transmission of TB by means of an infection control program. It explains the three levels of TB infection control in health care settings: (1) administrative controls to minimize areas where exposure may occur; (2) environmental controls to reduce the concentration of airborne TB bacteria; and (3) respiratory protective equipment to be used in situations that pose a high risk of exposure.

This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.

This is a planning document designed to facilitate the integration of strong public-private mix components into national TB strategic plans that are supposed to be the basis for Global Fund proposals and national budgeting processes, and will help drive a more comprehensive approach to provider engagement in TB care and prevention.